UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 175 filers reported holding UNIQURE NV in Q3 2021. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,420 | -50.7% | 211,646 | +66.5% | 0.01% | -65.9% |
| Q4 2022 | $2,881 | -99.8% | 127,108 | +41.7% | 0.04% | +127.8% |
| Q2 2022 | $1,671,000 | +320.9% | 89,684 | +368.2% | 0.02% | +800.0% |
| Q4 2021 | $397,000 | -71.0% | 19,155 | -57.0% | 0.00% | -84.6% |
| Q2 2021 | $1,371,000 | +188.0% | 44,532 | +320.9% | 0.01% | -7.1% |
| Q2 2020 | $476,000 | +64.7% | 10,579 | +5.5% | 0.01% | -65.9% |
| Q4 2018 | $289,000 | – | 10,032 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
| Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
| Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
| Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
| 683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
| Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
| Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
| Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
| Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
| Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |